Earth Corporation · TSE:4985
Earth — Q3 2025 Earnings Presentation
25 slides from Earth's earnings presentation, Nov 11, 2025
Slide 1: Earnings Briefing Materials for 3Q of the Fiscal Year Ending December 2025
Earnings Briefing Materials for 3Q of the Fiscal Year Ending December 2025 11/11/2025
Slide 2: Executive Summary
Executive Summary Sales: 142.9 B yen (vs. forecast: +1.1%; +1.55 B yen) Operating Income: 13.2 B yen (vs. forecast: +26.4%; +2.77 B yen) FY25.3Q • Sales generally followed the forecast trajectory, with contributions from newly consolidated Results PROTOLEAF, Inc., enabling plan achievement • Gross p
Slide 3: 3Q FY 12/2025 – Financial Result Highlights
3Q FY 12/2025 – Financial Result Highlights
Slide 4: Financial Result Highlights
Financial Result Highlights YoY : Increase in sales and profits. Vs. forecast : Sales exceeded the forecast, in part thanks to a revenue contribution from PROTOLEAF, Inc., which became a Group consolidated subsidiary. Operating profit achieved the plan due to improved gross profit margin and unu
Slide 5: Management Accounting Basis: Sales / GPM (24 vs 25)
Management Accounting Basis: Sales / GPM (24 vs 25) Domestic – Insecticides & Repellents: Higher sales & price revisions led to a profit improvement. Domestic – Homecare Products: Sales increased slightly, with profitability improving primarily, in bath salts and oral hygiene products. Gardeni
Slide 6: Domestic: Insecticides & Repellents Status Update
Domestic: Insecticides & Repellents Status Update Favorable weather conditions since mid-May persisted, resulting in a 101.3% increase compared to the previous period as of the end of September. Insect repellents & insecticides for cockroach & pest control, including new products, boosted. resul
Slide 7: Domestic: Homecare Products Status Update (Oral Hygiene Products)
Domestic: HomecareProducts Status Update （Oral Hygiene Products) Sales of the Mondamin series have been strong following its major renewal. Market share has increased since the renewal due to aggressive advertising and promotion. Market Size & Earth’s Market Share as of September 30, 2025 『Monda
Slide 8: Domestic: Homecare Products Status Update (Bath Salts)
Domestic: HomecareProducts Status Update （Bath Salts ) While the overall market is trending above the previous year, variations are seen depending on the dosage form. High-priced, high-value-added products such as Kikiyu and BARTH continue to grow. Sales growth driven by new products such as O
Slide 9: Overseas: Status Update (ASEAN Core)
Overseas: Status Update (ASEAN Core) (Unit: 0.1 B JPY) Thailand Vietnam Achieved both the previous year and sales forecast Sales exceeded the previous year on a local on a yen basis. currency basis. Steady growth in shipments to core accounts. Aiming to recover from the shortfall in sales to
Slide 10: Overseas: Status Update (Expansion in ASEAN, China, Exports)
Overseas: Status Update (Expansion in ASEAN, China, Exports) (Unit: 0.1 B JPY) Growth Areas (Malaysia & Philippines) China Exports Malaysia: Strong growth in Sales fell short of the forecast, Market weakness in Saudi insecticides & repellents and air but exceeded the previous Arabia and Hong K
Slide 11: General Environment and Sanitation Business Status Update
General Environment and Sanitation Business Status Update Increased demand for hygiene management services delivered with specialized knowledge, technology, and know-how has led to a rise in the number of contracts. As the sophistication of our services increases, the unit price per contract ris
Slide 12: Operating Income Change Factors (vs. Forecast)
Operating Income Change Factors (vs. Forecast) PROTOLEAF, Inc. became a consolidated subsidiary and positive changes to the sales composition, including a boost from price revisions, led to a profit overperformance. Advertising expenses are expected to be utilized in the fourth quarter. (Unit: 0
Slide 13: Progress of One-off Expenses
Progress of One-off Expenses (Incl. Structural Transformation) While actual resource deployment timings may vary, expenses for structural transformation and the Group’s 100th anniversary are on track with the plan. We will also be deploying resources for strategic expenses as needed, within a pr
Slide 14: Revision to Full-year Forecast
Revision to Full-year Forecast No changes from the upward revision made in the second quarter (Unit: 0.1 B JPY) 2025 Fcst. 2025 Rev. Diff. Key Forecast Revision Factors 2024 Res. Sales 1,750 1,780 ＋30.0 • Contribution from the consolidation of PROTOLEAF, Inc. 1,692 Gross • We now expect better gro
Slide 15: Progress Vs. Initial Operating Income Target (Quarterly / 3Q)
Progress Vs. Initial Operating Income Target (Quarterly / 3Q) (Unit: 0.1 B JPY) Q3 is progressing smoothly with no significant deviation from the forecast. Q1 Q2 Q3 Q4 Quarterly 62.7 72.8 51.0 59.0 49.8 57.8 -0.7 -5.0 -2.8 -42.6 -40.0 135.5 132.7 Quarterly Cumulative 110.0 105.0 62.6 65.0 51.0 107
Slide 16: Supplementary Materials: FY12/2025 3Q Results
Supplementary Materials: FY12/2025 3Q Results
Slide 17: Consolidated: Statement of Income
Consolidated: Statement of Income （Unit：million JPY） 3Q FY24 3Q FY25 3Q FY25 VS YoY vs.FCT FY12/25 Progress Realized Forecast Realized +/- YoY +/- FCT Initial Forecast ratio Sales 134,858 141,400 142,953 8,094 106.0% 1,553 101.1% 175,000 81.7% Cost of sales 79,122 82,050 81,892 2,769 103.5% - 157 99
Slide 18: Consolidated: Sales by Segment
Consolidated: Sales by Segment （Unit：million JPY） 3Q FY24 3Q FY25 3Q FY25 VS YoY vs.FCT FY12/25 Progress Realized Forecast Realized +/- YoY +/- FCT Initial Forecast ratio Insecticides & Repellents 59,207 0 61,264 2,057 103.5% 0 0.0% 0 0.0% Gardening products 3,619 0 6,917 3,297 191.1% 0 0 0 0.0% Ins
Slide 19: Consolidated: SG&A Expenses
Consolidated: SG&A Expenses （Unit：million JPY） 3Q FY24 3Q FY25 3Q FY25 VS YoY vs.FCT FY12/25 Progress Realized Forecast Realized +/- YoY +/- FCT Initial Forecast ratio Personal expenses 16,904 17,403 17,564 660 103.9% 161 100.9% 23,278 75.5% Shipping costs 3,673 3,872 4,162 489 113.3% 290 107.5% 5,0
Slide 20: Operating Income Change Factors (YoY)
Operating Income Change Factors (YoY) Increased revenue from Insecticides & Repellents and higher profit margins from shifting to higher- priced items contributed significantly Cost reduction efforts continue, though the impact of rising raw material prices persists; price adjustment measures of
Slide 21: Overview of Group Companies' Business Performance
Overview of Group Companies' Business Performance （Unit：million JPY） Earth Corporation BATHCLIN Corporation Hakugen Earth Co., Ltd. 3Q FY24 3Q FY25 3Q FY25 3Q FY24 3Q FY25 3Q FY25 3Q FY24 3Q FY25 3Q FY25 Realized Forecast Realized Realized Forecast Realized Realized Forecast Realized Sales 73,832 76
Slide 22: Overseas Results
Overseas Results (Unit: 0.1 billion JPY) Overseas Sales to External Customers Only (Excluding Intercompany Sales) Overseas OI (Simple sum) © Earth Corporation All Rights Reserved. supplement 21
Slide 23: Consolidated: Balance Sheet
Consolidated: Balance Sheet （Unit：million JPY） 3Q 3Q VS YoY End of FY24 FY25 +/- FY24 +/- Current Cash & deposits 20,790 21,035 245 17,007 4,028 assets Trade receivable 28,869 30,964 2,095 25,521 5,443 Inventories 28,699 30,961 2,261 29,885 1,075 Others 2,780 2,826 45 2,658 167 Non-current Property,
Slide 24: Consolidated: Capital expenditure, Depreciation expenses
Consolidated: Capital expenditure, Depreciation expenses （Unit：million JPY） FY2021 FY2022 FY2023 FY2024 FY2025 FY2021 FY2022 FY2023 FY2024 FY2025 Results Results Results Results Forecast Results Results Results Results Forecast CAPEX 2,928 5,878 7,504 4,376 4,952 Depreciation 3,537 3,853 4,118 4,424
Slide 25: Forward-looking statements disclaimer
This presentation contains forward-looking statements and financial results forecasts. These forward-looking statements and financial results forecasts were formulated on the basis of company assumptions based on the information available. These statements and forecasts are subject to risks and unce